City of Hope

www.cityofhope.org

 

ASH 2022 Conference Coverage
A

ASH 2022 NX-2127-001, a First-in-Human Trial of NX-2127, a BTK-Targeted Protein Degrader, in Patients With R/R CLL and B-Cell Malignancies

By ASH 2022 Conference Coverage FEATURING Alexey Danilov
By ASH 2022 Conference Coverage FEATURING Alexey Danilov
36 views
January 11, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey
Leukemia
08:47

New

Incorporating Pirtobrutinib and CAR-T Therapy Into CLL Practice

City of Hope

A. Danilov

36 views
03:06

CLL Treatment Sequencing: The Importance of First Choice

City of Hope

S. Rosen

313 views
08:42

Venetoclax vs. BTKis in CLL Treatment

City of Hope

A. Danilov

252 views
08:26

Primary Analysis of TRANSCEND CLL 004 - Liso-Cel in R/R CLL/SLL

City of Hope

T. Siddiqi

50 views
08:35

Liso-Cel in R/R CLL/SLL: Primary Analysis of the Phase 1/2, Single-A…

SOHO 2023 Eleventh Annual Meeting

T. Siddiqi

116 views
06:23

TKI-BiTE Combo in Ph+ALL: Integrating Expert Opinion With Clinical T…

City of Hope

I. Aldoss

75 views
06:57

ASH 2022 NX-2127-001, a First-in-Human Trial of NX-2127, a BTK-Targe…

ASH 2022 Conference Coverage

A. Danilov

36 views
06:20

Consolidation With Allogeneic HCT Improved Survival Outcomes of Adul…

ASH 2022 Conference Coverage

I. Aldoss

73 views
09:33

Assessing Comorbidities in CLL

City of Hope

A. Danilov

285 views
18:28

2020 SOHO Update on Optimizing Lymphodepletion Prior to CAR-T Therap…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

E. Budde

32 views
33:39

2020 SOHO Update on CAR-T for R/R AML: What Are the Current Limitati…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

E. Budde

34 views
25:04

How to Sequence Novel Agents in CLL

City of Hope

T. Siddiqi

414 views